Effects of repeated rifabutin administration on the pharmacokinetics of intravenous and oral ciprofloxacin in mice

Journal of Chemotherapy

Volumn 13, Issue 5, 2001, Pages 563-568

  Liu, X G ^a   Li, R C ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Bioavailability; Ciprofloxacin; Drug interaction; Mice; Pharmacokinetics; Rifabutin

Indexed keywords

CIPROFLOXACIN; RIFABUTIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; MALE; MOUSE; NONHUMAN; PLASMA CLEARANCE;

EID: 0034782347     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.5.563     Document Type: Article

References (22)

1. Rationale for the prevention of disseminated Mycobacterium-intracellulare complex disease
2. Fluoroquinolones: Antimicrobial agents of the '90s
3. Infections due to the Mycobacterium avium complex (MAC)
4. Antimicrobial activity of rifabutin in combination with two and three other antimicrobial agents against strains of Mycobacterium paratuberculosis
5. Inducing properties of rifabutin, and effects of the pharmacokinetics and metabolism of concomitant drugs
6. Inducing properties of rifampin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver
7. Induction and autoinduction properties of rifamycin derivatives: A review of animal and human studies
8. Enhanced elimination of ciprofloxacin after multiple-dose administration of rifampin to rabbits
9. Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human
10. Liquid chromatographic determination of ciprofloxacin in serum and urine
11. Noncompartmental analysis based on statistical moment theory
12. Testing for equality of area under the curves when using destructive measurement techniques
13. Pharmacokinetic and pharmacodynamic interactions between intravenous ciprofloxacin and oral ferrous sulfate
14. Disposition kinetics of ciprofloxacin in lactating goats
15. Doseranging pharmacokinetic study of ciprofloxacin after 200-,300-, and 400-mg intravenous doses
16. A model based assessment of redistribution dependent elimination and bioavailability of rifabutin
17. Drug redistribution and mean transit time concepts for nonlinear pharmacokinetic systems
18. Autoinduction of rifabutin metabolism in man
19. Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats
20. Pharmacokinetics, renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs
21. Pharmacokinetics of ciprofloxacin in cystic fibrosis
22. Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethyl antipyrine, and norantipyrine formation